Eli Lilly and Company Broadens Income Eligibility for Patient Assistance Programs

INDIANAPOLIS, Aug. 5 /PRNewswire-FirstCall/ -- In the midst of the down economy, many Americans have seen their financial situations change - for the worse - forcing them to make difficult sacrifices to afford medications or detrimental decisions to stop taking medicines.

“By making these changes, we are addressing a real concern for patients we have heard from in recent months. Many have lost their jobs and insurance coverage and need our help to stay on their medications,” said John C. Lechleiter, Ph.D., Eli Lilly and Company chairman, president and chief executive officer. “Patients are our first priority. By relaxing the income guidelines for Lilly’s patient assistance programs, more patients will qualify for Lilly’s patient assistance programs.”

Globally, over the past three years, Lilly has donated $883 million in products to patients and agencies throughout the world.

Lilly’s patient assistance programs

Access to affordable medications is a top priority for Lilly. This commitment is exemplified by Lilly’s various patient assistance programs, which provide needy patients access to the company’s portfolio of medications.

LillyMedicareAnswers(TM)

LillyMedicareAnswers is a patient assistance program that provides eligible Medicare recipients access to Lilly medications outside of their Medicare Part D plan. To learn more or obtain an application, call (877) RX-LILLY (1-877-795-4559) or visit www.lillymedicareanswers.com.

Partnership for Prescription Assistance

Lilly supports the Partnership for Prescription Assistance, which brings together America’s pharmaceutical companies, doctors, other health care providers, patient advocacy organizations and community groups to match patients with public and private prescription assistance programs for which they may be eligible for enrollment. Many of these programs are offered by individual pharmaceutical companies. For more information, call (888) 4PPA-NOW (888-477-2669) or visit www.pparx.org.

O-LLY

Eli Lilly and Company

MORE ON THIS TOPIC